Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Protein Array Analysis | 4 | 2021 | 504 | 1.130 |
Why?
|
Mammary Neoplasms, Animal | 6 | 2018 | 229 | 1.040 |
Why?
|
Wnt1 Protein | 7 | 2018 | 101 | 0.720 |
Why?
|
Proteomics | 5 | 2021 | 1422 | 0.630 |
Why?
|
Mammary Tumor Virus, Mouse | 5 | 2018 | 122 | 0.580 |
Why?
|
Mammary Glands, Animal | 7 | 2018 | 546 | 0.560 |
Why?
|
Gene Expression Profiling | 8 | 2016 | 5239 | 0.460 |
Why?
|
Breast Neoplasms | 17 | 2021 | 16049 | 0.400 |
Why?
|
Proteins | 2 | 2021 | 1986 | 0.390 |
Why?
|
Receptor, ErbB-2 | 8 | 2019 | 2616 | 0.380 |
Why?
|
Proteasome Endopeptidase Complex | 4 | 2016 | 592 | 0.380 |
Why?
|
Mice | 46 | 2021 | 35282 | 0.370 |
Why?
|
Signal Transduction | 17 | 2021 | 12133 | 0.370 |
Why?
|
Autoantigens | 4 | 2016 | 238 | 0.350 |
Why?
|
Animals | 47 | 2021 | 60946 | 0.290 |
Why?
|
Wnt Proteins | 4 | 2021 | 399 | 0.290 |
Why?
|
Gene Expression Regulation, Neoplastic | 12 | 2020 | 9064 | 0.280 |
Why?
|
Trans-Activators | 4 | 2003 | 1624 | 0.280 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 2 | 1999 | 208 | 0.280 |
Why?
|
Smad1 Protein | 4 | 2011 | 36 | 0.270 |
Why?
|
Genes, Dominant | 1 | 2006 | 342 | 0.260 |
Why?
|
T-Lymphocytes, Regulatory | 2 | 2020 | 717 | 0.240 |
Why?
|
Protein Processing, Post-Translational | 2 | 2021 | 802 | 0.240 |
Why?
|
Neoplasm Proteins | 1 | 2015 | 3288 | 0.220 |
Why?
|
Mice, Transgenic | 11 | 2013 | 4229 | 0.220 |
Why?
|
Prostatic Neoplasms, Castration-Resistant | 2 | 2020 | 464 | 0.220 |
Why?
|
Cell Line, Tumor | 17 | 2021 | 14850 | 0.220 |
Why?
|
Receptors, Estrogen | 4 | 2021 | 2122 | 0.220 |
Why?
|
Estrogen Receptor alpha | 3 | 2016 | 712 | 0.210 |
Why?
|
Neuroendocrine Tumors | 2 | 2020 | 649 | 0.210 |
Why?
|
Pyridines | 2 | 2020 | 1289 | 0.210 |
Why?
|
Cell Transformation, Neoplastic | 4 | 2018 | 2395 | 0.210 |
Why?
|
Pyrroles | 2 | 2017 | 594 | 0.210 |
Why?
|
ErbB Receptors | 3 | 2021 | 2329 | 0.200 |
Why?
|
Friedreich Ataxia | 1 | 2021 | 40 | 0.190 |
Why?
|
Carcinoma, Renal Cell | 3 | 2020 | 2387 | 0.190 |
Why?
|
Calcium | 2 | 1999 | 1557 | 0.190 |
Why?
|
DNA-Binding Proteins | 4 | 2018 | 4907 | 0.190 |
Why?
|
Indoles | 2 | 2017 | 1021 | 0.190 |
Why?
|
Neuroblastoma | 2 | 2020 | 695 | 0.180 |
Why?
|
Enterocytes | 1 | 2021 | 75 | 0.180 |
Why?
|
Insulins | 1 | 2020 | 20 | 0.180 |
Why?
|
Retinoids | 1 | 2021 | 171 | 0.180 |
Why?
|
Ileum | 1 | 2021 | 168 | 0.180 |
Why?
|
Disease Models, Animal | 9 | 2021 | 7415 | 0.180 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2021 | 164 | 0.180 |
Why?
|
Protein Kinase C | 2 | 2018 | 397 | 0.180 |
Why?
|
Cell Proliferation | 9 | 2020 | 7300 | 0.170 |
Why?
|
Isotretinoin | 1 | 2020 | 158 | 0.170 |
Why?
|
Mevalonic Acid | 1 | 2019 | 34 | 0.170 |
Why?
|
Biomarkers, Tumor | 4 | 2020 | 10623 | 0.170 |
Why?
|
Quality Control | 1 | 2021 | 461 | 0.170 |
Why?
|
Fibroblasts | 4 | 2021 | 1689 | 0.170 |
Why?
|
Female | 38 | 2021 | 147098 | 0.170 |
Why?
|
Mice, Knockout | 6 | 2016 | 5793 | 0.170 |
Why?
|
Adaptation, Physiological | 1 | 2021 | 365 | 0.170 |
Why?
|
Triple Negative Breast Neoplasms | 2 | 2020 | 1295 | 0.160 |
Why?
|
Stem Cells | 3 | 2018 | 1243 | 0.160 |
Why?
|
Intestinal Neoplasms | 1 | 2021 | 197 | 0.160 |
Why?
|
Phenylurea Compounds | 2 | 2020 | 598 | 0.160 |
Why?
|
MAP Kinase Signaling System | 2 | 2021 | 885 | 0.160 |
Why?
|
Drug Resistance, Neoplasm | 7 | 2019 | 5292 | 0.160 |
Why?
|
Receptors, CCR2 | 1 | 2018 | 45 | 0.160 |
Why?
|
Myotonin-Protein Kinase | 1 | 2018 | 36 | 0.160 |
Why?
|
Transcriptome | 2 | 2018 | 1951 | 0.160 |
Why?
|
NIMA-Related Kinases | 1 | 2018 | 11 | 0.160 |
Why?
|
TNF Receptor-Associated Factor 4 | 1 | 2018 | 24 | 0.160 |
Why?
|
Cytokines | 3 | 2017 | 2867 | 0.160 |
Why?
|
Receptor, trkA | 1 | 2018 | 39 | 0.160 |
Why?
|
Prodrugs | 1 | 2020 | 220 | 0.160 |
Why?
|
Proteome | 2 | 2021 | 577 | 0.160 |
Why?
|
Tamoxifen | 4 | 2016 | 883 | 0.150 |
Why?
|
MutL Proteins | 1 | 2017 | 30 | 0.150 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2021 | 480 | 0.150 |
Why?
|
Bone Neoplasms | 3 | 2021 | 2652 | 0.150 |
Why?
|
MAP Kinase Kinase 4 | 1 | 2018 | 143 | 0.150 |
Why?
|
Pancreatic Neoplasms | 4 | 2020 | 5227 | 0.150 |
Why?
|
Biomarkers | 4 | 2021 | 5172 | 0.150 |
Why?
|
Bone and Bones | 1 | 2021 | 604 | 0.150 |
Why?
|
Muscle Weakness | 1 | 2018 | 115 | 0.150 |
Why?
|
Pulmonary Alveoli | 1 | 2018 | 210 | 0.150 |
Why?
|
Anilides | 1 | 2020 | 287 | 0.150 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2019 | 224 | 0.150 |
Why?
|
Cell Division | 3 | 2013 | 2554 | 0.150 |
Why?
|
Checkpoint Kinase 2 | 1 | 2017 | 130 | 0.150 |
Why?
|
Androgen Antagonists | 1 | 2020 | 429 | 0.140 |
Why?
|
Mammary Neoplasms, Experimental | 3 | 2015 | 505 | 0.140 |
Why?
|
Batch Cell Culture Techniques | 1 | 2016 | 8 | 0.140 |
Why?
|
Angiogenesis Inducing Agents | 1 | 2017 | 107 | 0.140 |
Why?
|
GTPase-Activating Proteins | 1 | 2017 | 128 | 0.140 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2020 | 627 | 0.140 |
Why?
|
Myotonic Dystrophy | 1 | 2018 | 153 | 0.140 |
Why?
|
Ubiquitin | 2 | 2021 | 342 | 0.140 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2017 | 131 | 0.140 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 1 | 2016 | 65 | 0.140 |
Why?
|
Hexosamines | 1 | 2016 | 26 | 0.140 |
Why?
|
Metformin | 1 | 2020 | 390 | 0.140 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2017 | 203 | 0.140 |
Why?
|
Interleukin-2 | 1 | 2020 | 851 | 0.140 |
Why?
|
Morpholines | 1 | 2018 | 293 | 0.140 |
Why?
|
Lipopolysaccharides | 1 | 2018 | 588 | 0.130 |
Why?
|
Aminopyridines | 1 | 2018 | 219 | 0.130 |
Why?
|
Polyethylene Glycols | 1 | 2020 | 636 | 0.130 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2018 | 522 | 0.130 |
Why?
|
src-Family Kinases | 1 | 2018 | 480 | 0.130 |
Why?
|
Bronchopulmonary Dysplasia | 1 | 2018 | 172 | 0.130 |
Why?
|
Wnt Signaling Pathway | 2 | 2021 | 446 | 0.130 |
Why?
|
Spheroids, Cellular | 1 | 2016 | 217 | 0.130 |
Why?
|
Oligonucleotide Array Sequence Analysis | 4 | 2016 | 2520 | 0.130 |
Why?
|
Cell Cycle | 5 | 2020 | 2115 | 0.130 |
Why?
|
Hypothalamus | 1 | 2017 | 255 | 0.130 |
Why?
|
Humans | 42 | 2021 | 270506 | 0.130 |
Why?
|
Myeloid-Derived Suppressor Cells | 1 | 2016 | 106 | 0.130 |
Why?
|
Stromal Cells | 2 | 2016 | 831 | 0.130 |
Why?
|
Tissue Scaffolds | 1 | 2016 | 142 | 0.130 |
Why?
|
Cardiomyopathies | 1 | 2021 | 622 | 0.130 |
Why?
|
Neoplasm Transplantation | 4 | 2021 | 1532 | 0.130 |
Why?
|
MicroRNAs | 2 | 2020 | 2954 | 0.130 |
Why?
|
Everolimus | 1 | 2017 | 419 | 0.120 |
Why?
|
I-kappa B Kinase | 1 | 2016 | 251 | 0.120 |
Why?
|
Printing, Three-Dimensional | 1 | 2016 | 137 | 0.120 |
Why?
|
Cyclic AMP-Dependent Protein Kinase Catalytic Subunits | 1 | 2014 | 4 | 0.120 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2015 | 186 | 0.120 |
Why?
|
Carcinogenesis | 3 | 2020 | 1048 | 0.120 |
Why?
|
Interleukin-8 | 1 | 2016 | 529 | 0.120 |
Why?
|
Phosphorylation | 6 | 2019 | 4885 | 0.120 |
Why?
|
Tissue Engineering | 1 | 2016 | 269 | 0.120 |
Why?
|
Epidermal Growth Factor | 1 | 1995 | 427 | 0.110 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2019 | 1293 | 0.110 |
Why?
|
Casein Kinase Idelta | 1 | 2013 | 6 | 0.110 |
Why?
|
Neoplasm Metastasis | 2 | 2021 | 5238 | 0.110 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2020 | 1559 | 0.110 |
Why?
|
Aging, Premature | 1 | 2013 | 40 | 0.110 |
Why?
|
Sarcoma, Ewing | 1 | 2017 | 418 | 0.110 |
Why?
|
Synapses | 1 | 2017 | 530 | 0.110 |
Why?
|
STAT5 Transcription Factor | 2 | 2013 | 222 | 0.110 |
Why?
|
Hypertension, Pulmonary | 1 | 2018 | 469 | 0.110 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2020 | 1459 | 0.110 |
Why?
|
Up-Regulation | 2 | 2018 | 2480 | 0.110 |
Why?
|
Guidelines as Topic | 1 | 2015 | 382 | 0.110 |
Why?
|
MCF-7 Cells | 3 | 2021 | 551 | 0.110 |
Why?
|
Colitis | 1 | 2016 | 338 | 0.110 |
Why?
|
Hyperthermia, Induced | 1 | 2017 | 516 | 0.110 |
Why?
|
Enzyme Activation | 4 | 2018 | 1798 | 0.110 |
Why?
|
Xenograft Model Antitumor Assays | 6 | 2020 | 3930 | 0.110 |
Why?
|
Kidney Neoplasms | 2 | 2017 | 3097 | 0.100 |
Why?
|
Tumor Microenvironment | 2 | 2021 | 2980 | 0.100 |
Why?
|
Mice, Inbred C57BL | 7 | 2020 | 7154 | 0.100 |
Why?
|
Heterografts | 3 | 2019 | 749 | 0.100 |
Why?
|
Protein Kinases | 1 | 2016 | 888 | 0.100 |
Why?
|
Inhibitor of Differentiation Proteins | 1 | 2011 | 23 | 0.100 |
Why?
|
Lung Neoplasms | 3 | 2018 | 11816 | 0.100 |
Why?
|
Receptors, Progesterone | 1 | 2017 | 1415 | 0.100 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 2013 | 227 | 0.100 |
Why?
|
Precancerous Conditions | 1 | 2018 | 1079 | 0.100 |
Why?
|
Keratin-6 | 1 | 2011 | 39 | 0.100 |
Why?
|
RNA, Small Interfering | 4 | 2018 | 2221 | 0.100 |
Why?
|
Smad Proteins | 2 | 2002 | 92 | 0.090 |
Why?
|
Neoplastic Stem Cells | 2 | 2017 | 1469 | 0.090 |
Why?
|
Bone Development | 1 | 2011 | 82 | 0.090 |
Why?
|
Antigens, Viral, Tumor | 1 | 2010 | 47 | 0.090 |
Why?
|
Polyomavirus | 1 | 2010 | 30 | 0.090 |
Why?
|
Neovascularization, Pathologic | 1 | 2017 | 1574 | 0.090 |
Why?
|
Antineoplastic Agents, Hormonal | 3 | 2016 | 848 | 0.090 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2011 | 343 | 0.090 |
Why?
|
Cell Movement | 4 | 2021 | 2498 | 0.090 |
Why?
|
Nerve Tissue Proteins | 1 | 2017 | 1508 | 0.090 |
Why?
|
Drug Synergism | 3 | 2020 | 1336 | 0.090 |
Why?
|
Genes, erbB-2 | 1 | 2010 | 232 | 0.090 |
Why?
|
Cell Line | 5 | 2016 | 5128 | 0.080 |
Why?
|
Forkhead Transcription Factors | 1 | 2014 | 770 | 0.080 |
Why?
|
Estrogens | 2 | 2010 | 758 | 0.080 |
Why?
|
Transcription, Genetic | 4 | 2017 | 3148 | 0.080 |
Why?
|
Cornea | 1 | 2014 | 633 | 0.080 |
Why?
|
Mice, SCID | 3 | 2018 | 1864 | 0.080 |
Why?
|
NF-kappa B | 1 | 2016 | 1584 | 0.080 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2017 | 1798 | 0.080 |
Why?
|
Smad8 Protein | 1 | 2008 | 9 | 0.080 |
Why?
|
Smad5 Protein | 1 | 2008 | 29 | 0.080 |
Why?
|
Activin Receptors, Type I | 1 | 2008 | 50 | 0.080 |
Why?
|
Bone Morphogenetic Protein Receptors, Type I | 1 | 2008 | 75 | 0.080 |
Why?
|
Angiogenesis Inhibitors | 1 | 2015 | 1261 | 0.080 |
Why?
|
Apoptosis | 6 | 2019 | 7755 | 0.080 |
Why?
|
Mice, Nude | 4 | 2021 | 4343 | 0.080 |
Why?
|
Neoplasms, Experimental | 1 | 2011 | 749 | 0.070 |
Why?
|
Cell Survival | 3 | 2020 | 3061 | 0.070 |
Why?
|
Protein Binding | 4 | 2019 | 3480 | 0.070 |
Why?
|
Male | 16 | 2021 | 127458 | 0.070 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2014 | 1569 | 0.070 |
Why?
|
Antineoplastic Agents | 3 | 2019 | 14502 | 0.070 |
Why?
|
DNA Repair | 1 | 2015 | 1906 | 0.070 |
Why?
|
DNA Damage | 1 | 2015 | 1987 | 0.070 |
Why?
|
Mullerian Ducts | 1 | 2008 | 78 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-akt | 3 | 2020 | 2084 | 0.070 |
Why?
|
Autophagy | 1 | 2013 | 931 | 0.070 |
Why?
|
Lung | 1 | 2018 | 3241 | 0.070 |
Why?
|
Avian Sarcoma Viruses | 1 | 2006 | 42 | 0.070 |
Why?
|
Epithelial-Mesenchymal Transition | 3 | 2020 | 991 | 0.070 |
Why?
|
Antigens, Polyomavirus Transforming | 1 | 2006 | 110 | 0.070 |
Why?
|
Cells, Cultured | 3 | 2021 | 5663 | 0.070 |
Why?
|
Ovary | 1 | 2010 | 684 | 0.070 |
Why?
|
Ubiquitination | 2 | 2019 | 579 | 0.070 |
Why?
|
Skin | 3 | 2013 | 1283 | 0.070 |
Why?
|
Ovariectomy | 3 | 2017 | 336 | 0.070 |
Why?
|
Gene Knockdown Techniques | 2 | 2019 | 1082 | 0.070 |
Why?
|
Hypertension | 1 | 2015 | 1584 | 0.070 |
Why?
|
Estradiol | 3 | 2017 | 761 | 0.060 |
Why?
|
Mice, Inbred NOD | 2 | 2018 | 902 | 0.060 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2008 | 634 | 0.060 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2011 | 1511 | 0.060 |
Why?
|
Protein Kinase Inhibitors | 1 | 2020 | 4884 | 0.060 |
Why?
|
HEK293 Cells | 2 | 2021 | 1512 | 0.060 |
Why?
|
Animals, Newborn | 2 | 2018 | 1347 | 0.060 |
Why?
|
Drug Therapy, Combination | 2 | 2020 | 2346 | 0.060 |
Why?
|
Genes, Neoplasm | 1 | 2005 | 328 | 0.060 |
Why?
|
Hyperplasia | 1 | 2005 | 566 | 0.060 |
Why?
|
Receptor, IGF Type 1 | 2 | 2020 | 350 | 0.060 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2010 | 1228 | 0.060 |
Why?
|
Disease Progression | 3 | 2021 | 6888 | 0.060 |
Why?
|
COS Cells | 2 | 2000 | 387 | 0.060 |
Why?
|
Base Sequence | 2 | 2018 | 4929 | 0.050 |
Why?
|
Zebrafish Proteins | 1 | 2003 | 163 | 0.050 |
Why?
|
Embryo, Mammalian | 2 | 2017 | 749 | 0.050 |
Why?
|
Melanoma | 1 | 2020 | 5444 | 0.050 |
Why?
|
Quinazolines | 3 | 2015 | 934 | 0.050 |
Why?
|
Immunoblotting | 2 | 2011 | 898 | 0.050 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2005 | 668 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2006 | 833 | 0.050 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2020 | 1706 | 0.050 |
Why?
|
Neoplasm Invasiveness | 2 | 2021 | 4052 | 0.050 |
Why?
|
Aldehyde Oxidoreductases | 1 | 2021 | 34 | 0.050 |
Why?
|
Prognosis | 5 | 2020 | 22229 | 0.050 |
Why?
|
Iron-Binding Proteins | 1 | 2021 | 35 | 0.050 |
Why?
|
Genetic Vectors | 1 | 2006 | 1712 | 0.050 |
Why?
|
Neoplasm Micrometastasis | 1 | 2021 | 50 | 0.050 |
Why?
|
Gap Junctions | 1 | 2021 | 50 | 0.050 |
Why?
|
Prostatic Neoplasms | 1 | 2018 | 5936 | 0.050 |
Why?
|
5' Untranslated Regions | 1 | 2000 | 99 | 0.050 |
Why?
|
Liver Neoplasms | 1 | 2017 | 4773 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2020 | 128 | 0.040 |
Why?
|
ras GTPase-Activating Proteins | 1 | 2020 | 31 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 2020 | 169 | 0.040 |
Why?
|
Receptors, Interleukin-2 | 1 | 2020 | 183 | 0.040 |
Why?
|
Genes | 1 | 2000 | 478 | 0.040 |
Why?
|
Longevity | 1 | 2021 | 154 | 0.040 |
Why?
|
Lanthanum | 1 | 1999 | 5 | 0.040 |
Why?
|
Enhancer of Zeste Homolog 2 Protein | 1 | 2021 | 256 | 0.040 |
Why?
|
Intracellular Fluid | 1 | 1999 | 46 | 0.040 |
Why?
|
Virulence Factors, Bordetella | 1 | 1999 | 41 | 0.040 |
Why?
|
Thapsigargin | 1 | 1999 | 41 | 0.040 |
Why?
|
Nifedipine | 1 | 1999 | 25 | 0.040 |
Why?
|
Type C Phospholipases | 1 | 1999 | 54 | 0.040 |
Why?
|
Introns | 1 | 2000 | 435 | 0.040 |
Why?
|
Tissue Array Analysis | 1 | 2021 | 764 | 0.040 |
Why?
|
Verapamil | 1 | 1999 | 79 | 0.040 |
Why?
|
Pertussis Toxin | 1 | 1999 | 59 | 0.040 |
Why?
|
Osteogenesis | 1 | 2021 | 262 | 0.040 |
Why?
|
Phospholipase C gamma | 1 | 1999 | 58 | 0.040 |
Why?
|
DNA, Complementary | 1 | 2000 | 880 | 0.040 |
Why?
|
Clonal Evolution | 1 | 2021 | 252 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-raf | 1 | 1999 | 83 | 0.040 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2000 | 1006 | 0.040 |
Why?
|
Tissue Distribution | 1 | 2000 | 907 | 0.040 |
Why?
|
Extracellular Space | 1 | 1999 | 134 | 0.040 |
Why?
|
Green Fluorescent Proteins | 1 | 2021 | 701 | 0.040 |
Why?
|
Calcium Channel Blockers | 1 | 1999 | 135 | 0.040 |
Why?
|
Genes, Reporter | 1 | 2021 | 809 | 0.040 |
Why?
|
Sequence Alignment | 1 | 2000 | 847 | 0.040 |
Why?
|
CELF1 Protein | 1 | 2018 | 46 | 0.040 |
Why?
|
Cell Differentiation | 2 | 2021 | 4163 | 0.040 |
Why?
|
Immunohistochemistry | 3 | 2011 | 7701 | 0.040 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2019 | 283 | 0.040 |
Why?
|
In Vitro Techniques | 1 | 2021 | 1638 | 0.040 |
Why?
|
RNA, Messenger | 3 | 2018 | 6221 | 0.040 |
Why?
|
Cell Communication | 1 | 2021 | 506 | 0.040 |
Why?
|
Calmodulin | 1 | 1999 | 248 | 0.040 |
Why?
|
Cell Growth Processes | 1 | 2018 | 342 | 0.040 |
Why?
|
Mechanistic Target of Rapamycin Complex 1 | 1 | 2019 | 271 | 0.040 |
Why?
|
Chemokine CCL2 | 1 | 2018 | 205 | 0.040 |
Why?
|
Trinucleotide Repeat Expansion | 1 | 2018 | 131 | 0.040 |
Why?
|
cdc42 GTP-Binding Protein | 1 | 2017 | 44 | 0.040 |
Why?
|
Amino Acid Sequence | 2 | 2000 | 4278 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2020 | 656 | 0.040 |
Why?
|
Protein Transport | 1 | 2019 | 745 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2015 | 10254 | 0.040 |
Why?
|
Genotype | 1 | 2005 | 4167 | 0.040 |
Why?
|
Pancreatic Stellate Cells | 1 | 2017 | 79 | 0.040 |
Why?
|
p21-Activated Kinases | 1 | 2017 | 125 | 0.040 |
Why?
|
Exons | 1 | 2000 | 1351 | 0.040 |
Why?
|
Feedback, Physiological | 1 | 2017 | 196 | 0.040 |
Why?
|
Trastuzumab | 1 | 2019 | 718 | 0.030 |
Why?
|
Isoenzymes | 1 | 1999 | 633 | 0.030 |
Why?
|
Molecular Sequence Data | 2 | 2000 | 6123 | 0.030 |
Why?
|
Transcription Factor AP-1 | 1 | 2017 | 253 | 0.030 |
Why?
|
Glutathione Transferase | 1 | 2017 | 367 | 0.030 |
Why?
|
Dextran Sulfate | 1 | 2016 | 72 | 0.030 |
Why?
|
Tumor Suppressor Proteins | 2 | 2019 | 1876 | 0.030 |
Why?
|
Phenotype | 2 | 2019 | 6395 | 0.030 |
Why?
|
ras Proteins | 1 | 2020 | 783 | 0.030 |
Why?
|
Chromatography, Ion Exchange | 1 | 1995 | 84 | 0.030 |
Why?
|
Myelin Basic Protein | 1 | 1995 | 85 | 0.030 |
Why?
|
Tenascin | 1 | 2015 | 56 | 0.030 |
Why?
|
Gene Deletion | 1 | 2021 | 1472 | 0.030 |
Why?
|
Transcriptional Activation | 1 | 2000 | 1096 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2020 | 1162 | 0.030 |
Why?
|
Down-Regulation | 1 | 2021 | 2113 | 0.030 |
Why?
|
Mass Spectrometry | 1 | 2018 | 717 | 0.030 |
Why?
|
Genes, p53 | 2 | 2013 | 1122 | 0.030 |
Why?
|
HCT116 Cells | 1 | 2016 | 353 | 0.030 |
Why?
|
Transfection | 2 | 2010 | 2988 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2017 | 849 | 0.030 |
Why?
|
Ipilimumab | 1 | 2020 | 749 | 0.030 |
Why?
|
Aromatase Inhibitors | 1 | 2017 | 312 | 0.030 |
Why?
|
Lymphocyte Activation | 1 | 2020 | 1698 | 0.030 |
Why?
|
Ligands | 1 | 2017 | 1009 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2017 | 1082 | 0.030 |
Why?
|
Gene Expression Regulation | 2 | 2017 | 4067 | 0.030 |
Why?
|
Proto-Oncogene Proteins | 1 | 2003 | 2547 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2020 | 1589 | 0.030 |
Why?
|
Drug Design | 1 | 2016 | 383 | 0.030 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2016 | 253 | 0.030 |
Why?
|
E-Selectin | 1 | 2014 | 105 | 0.030 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2014 | 123 | 0.030 |
Why?
|
Forkhead Box Protein O1 | 1 | 2014 | 163 | 0.030 |
Why?
|
Gene Amplification | 1 | 2016 | 745 | 0.030 |
Why?
|
Treatment Outcome | 4 | 2017 | 34185 | 0.030 |
Why?
|
Gene Silencing | 1 | 2016 | 838 | 0.030 |
Why?
|
RNA Interference | 1 | 2018 | 1411 | 0.030 |
Why?
|
Hep G2 Cells | 1 | 2013 | 155 | 0.030 |
Why?
|
Primary Cell Culture | 1 | 2014 | 207 | 0.030 |
Why?
|
Cerebral Cortex | 1 | 2017 | 628 | 0.030 |
Why?
|
Human Umbilical Vein Endothelial Cells | 1 | 2014 | 174 | 0.030 |
Why?
|
Swine | 1 | 2017 | 1610 | 0.030 |
Why?
|
Retroviridae | 1 | 2013 | 323 | 0.030 |
Why?
|
Sirtuin 1 | 1 | 2013 | 83 | 0.030 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2016 | 759 | 0.030 |
Why?
|
Sequence Analysis, DNA | 1 | 2000 | 2506 | 0.030 |
Why?
|
RNA-Binding Proteins | 1 | 2018 | 1007 | 0.030 |
Why?
|
Promoter Regions, Genetic | 1 | 2019 | 3105 | 0.030 |
Why?
|
Collagen | 1 | 2015 | 747 | 0.030 |
Why?
|
Kinetics | 1 | 1995 | 2098 | 0.030 |
Why?
|
DNA | 1 | 2000 | 2742 | 0.030 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2020 | 1658 | 0.030 |
Why?
|
Proteolysis | 1 | 2014 | 375 | 0.030 |
Why?
|
Models, Biological | 2 | 2013 | 3254 | 0.030 |
Why?
|
Bromodeoxyuridine | 1 | 2011 | 141 | 0.030 |
Why?
|
Neovascularization, Physiologic | 1 | 2014 | 355 | 0.020 |
Why?
|
Middle Aged | 4 | 2021 | 89424 | 0.020 |
Why?
|
Avian Leukosis Virus | 1 | 2011 | 12 | 0.020 |
Why?
|
Diet, High-Fat | 1 | 2013 | 250 | 0.020 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2015 | 446 | 0.020 |
Why?
|
Trabecular Meshwork | 1 | 2011 | 12 | 0.020 |
Why?
|
Fatty Liver | 1 | 2013 | 250 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 1999 | 1937 | 0.020 |
Why?
|
Gene Expression | 1 | 2019 | 3593 | 0.020 |
Why?
|
Epithelial Cells | 2 | 2010 | 1848 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2021 | 6269 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2017 | 1076 | 0.020 |
Why?
|
Collagen Type II | 1 | 2011 | 39 | 0.020 |
Why?
|
Survival Rate | 2 | 2020 | 12429 | 0.020 |
Why?
|
In Situ Nick-End Labeling | 1 | 2011 | 462 | 0.020 |
Why?
|
Neoplasms | 1 | 2017 | 15698 | 0.020 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2011 | 217 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2018 | 1328 | 0.020 |
Why?
|
Rats | 1 | 2020 | 6204 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2015 | 2401 | 0.020 |
Why?
|
Alkaline Phosphatase | 1 | 2011 | 208 | 0.020 |
Why?
|
Oncogenes | 1 | 2013 | 677 | 0.020 |
Why?
|
X-Ray Microtomography | 1 | 2011 | 133 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2018 | 5028 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2013 | 487 | 0.020 |
Why?
|
HeLa Cells | 1 | 2013 | 1653 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2017 | 5509 | 0.020 |
Why?
|
Chickens | 1 | 2010 | 527 | 0.020 |
Why?
|
Aged | 3 | 2021 | 72809 | 0.020 |
Why?
|
Phosphoproteins | 1 | 1995 | 1177 | 0.020 |
Why?
|
Aorta | 1 | 2014 | 707 | 0.020 |
Why?
|
Intestinal Mucosa | 1 | 2016 | 1104 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2013 | 518 | 0.020 |
Why?
|
Sulfonamides | 1 | 1999 | 1896 | 0.020 |
Why?
|
Mutation | 3 | 2019 | 15579 | 0.020 |
Why?
|
DNA Methylation | 1 | 2019 | 2734 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2020 | 30768 | 0.020 |
Why?
|
Neoplasm Staging | 2 | 2017 | 13880 | 0.020 |
Why?
|
Progesterone | 1 | 2011 | 528 | 0.020 |
Why?
|
Inflammation | 1 | 2018 | 2568 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2000 | 3385 | 0.020 |
Why?
|
Antibodies, Monoclonal, Humanized | 1 | 2020 | 3362 | 0.020 |
Why?
|
Genome, Human | 1 | 2016 | 1897 | 0.020 |
Why?
|
Pregnancy | 2 | 2013 | 7820 | 0.020 |
Why?
|
Adult | 3 | 2021 | 80609 | 0.020 |
Why?
|
Real-Time Polymerase Chain Reaction | 1 | 2011 | 1232 | 0.020 |
Why?
|
Colonic Neoplasms | 1 | 2016 | 1429 | 0.020 |
Why?
|
Anti-Mullerian Hormone | 1 | 2008 | 65 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2021 | 5705 | 0.020 |
Why?
|
Cohort Studies | 1 | 2020 | 9480 | 0.020 |
Why?
|
Oncogenic Viruses | 1 | 2006 | 18 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2008 | 638 | 0.020 |
Why?
|
Neurons | 1 | 2017 | 2385 | 0.020 |
Why?
|
Adolescent | 2 | 2021 | 32280 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2011 | 2049 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2017 | 9002 | 0.020 |
Why?
|
Mitogens | 1 | 2005 | 76 | 0.020 |
Why?
|
Algorithms | 1 | 2016 | 3983 | 0.020 |
Why?
|
Survival Analysis | 1 | 2016 | 9323 | 0.020 |
Why?
|
Blotting, Western | 1 | 2011 | 3595 | 0.020 |
Why?
|
Infertility, Male | 1 | 2008 | 306 | 0.020 |
Why?
|
Cyclin D1 | 1 | 2006 | 582 | 0.010 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2005 | 257 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2015 | 10092 | 0.010 |
Why?
|
Pyrimidines | 1 | 2015 | 3603 | 0.010 |
Why?
|
Recurrence | 1 | 2011 | 4875 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2011 | 5122 | 0.010 |
Why?
|
Young Adult | 1 | 2021 | 22103 | 0.010 |
Why?
|
Infant, Newborn | 1 | 1995 | 8544 | 0.010 |
Why?
|
Genes, myc | 1 | 2003 | 360 | 0.010 |
Why?
|
Cytoskeletal Proteins | 1 | 2003 | 514 | 0.010 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2013 | 3620 | 0.010 |
Why?
|
PTEN Phosphohydrolase | 1 | 2005 | 999 | 0.010 |
Why?
|
Precipitin Tests | 1 | 2000 | 336 | 0.010 |
Why?
|
beta Catenin | 1 | 2003 | 697 | 0.010 |
Why?
|
Smad2 Protein | 1 | 2000 | 94 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2008 | 5114 | 0.010 |
Why?
|
E1A-Associated p300 Protein | 1 | 2000 | 93 | 0.010 |
Why?
|
Proline | 1 | 2000 | 130 | 0.010 |
Why?
|
Smad4 Protein | 1 | 2000 | 201 | 0.010 |
Why?
|
Cytoplasm | 1 | 2000 | 652 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2005 | 1787 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 2000 | 1079 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2000 | 1503 | 0.010 |
Why?
|
Infant | 1 | 2011 | 13785 | 0.010 |
Why?
|
Child, Preschool | 1 | 2011 | 16760 | 0.010 |
Why?
|
Time Factors | 1 | 2008 | 13255 | 0.010 |
Why?
|
Risk Factors | 1 | 2011 | 18238 | 0.010 |
Why?
|
Child | 1 | 2011 | 30138 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2008 | 16258 | 0.000 |
Why?
|